Observational studyBMC infectious diseases2026
Ferroptosis and sepsis-induced myocardial injury: a prospective clinical study.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSepsis-induced myocardial injury (SIMI) is a common and severe complication of sepsis associated with increased mortality, yet its underlying mechanisms are not fully elucidated. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation and oxidative stress, has been implicated in preclinical models of septic cardiomyopathy. However, clinical evidence in humans remains limited, and the specificity of related biomarkers requires careful interpretation.
methodsThis prospective observational study enrolled 180 ICU-admitted sepsis patients (91 with SIMI and 89 without) from January to June 2025. Serum ferroptosis-related biomarkers, including malondialdehyde (MDA), lipid peroxidation (LPO), glutathione (GSH), reactive oxygen species (ROS), and ferrous iron (Fe²⁺), were measured at 24 h post-admission. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curves, and independent predictors were identified via multivariable logistic regression adjusting for clinical confounders.
resultsCompared with the non-SIMI group, SIMI patients showed significantly altered ferroptosis-related markers (all P < 0.001): higher MDA [6.08 (5.38-6.67) vs. 4.47 (3.92-5.30) nmol/mL], LPO, ROS, and Fe²⁺, and lower GSH. ROC analysis demonstrated moderate-to-good diagnostic discrimination for SIMI (AUC 0.746-0.825), with Fe²⁺ showing the highest AUC (0.825), followed by ROS (0.793) and MDA (0.787); these outperformed BNP but were inferior to cTnI. Multivariable logistic regression identified Fe²⁺ (OR = 11.883, P < 0.001) as the only independent ferroptosis-related predictor of SIMI, alongside cTnI and APACHE II score. The full model exhibited excellent discrimination (AUC = 0.989) and good calibration (Hosmer-Lemeshow P = 0.935).
conclusionsElevated ferroptosis-related biomarkers reflecting systemic oxidative stress and iron dysregulation are significantly associated with SIMI, with Fe²⁺ emerging as an independent predictor. These biomarkers provide additive diagnostic value beyond traditional cardiac markers but are not specific for ferroptosis as a regulated cell death mechanism and likely represent broader redox imbalance in severe sepsis. These findings support further investigation into iron-targeted and oxidative stress-modulating strategies in septic cardiac dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.